The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
about
Potential of Endocannabinoids to Control Bladder Pain.The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors.Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
P2860
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@en
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@nl
type
label
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@en
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@nl
prefLabel
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@en
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@nl
P2860
P1476
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease.
@en
P2093
Nicholas Manolios
Nicola Barrie
P2860
P304
P356
10.5152/EURJRHEUM.2017.17025
P577
2017-09-01T00:00:00Z